Transgene’s LiverCancer Drug Shows Efficacy In Animal Studies
Transgene has employed a novel gene silencing (within RNAi platform) technology to develop this drug. The technology involves highly selective knock-down of specific liver cancer producing gene targets,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.